Furthermore, it addresses the FDA’s communications Using the applicant, the retention of information that assistance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of an SE report to a whole new applicant and Digital submission from the SE repor